⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL375634 | 0.86 | LMNA (0.53) | — | |
| SCHEMBL8694965 | 0.85 | TSHR (0.42) | — | |
| SCHEMBL8696479 | 0.85 | TSHR (0.52) | — | |
| SCHEMBL28778289 | 0.83 | TSHR (0.50) | — | |
| SCHEMBL1766170 | 0.83 | LMNA (0.50) | — | |
| SCHEMBL16134190 | 0.83 | LMNA (0.50) | — | |
| SCHEMBL1766172 | 0.83 | LMNA (0.50) | — | |
| SCHEMBL1766162 | 0.83 | LMNA (0.50) | — | |
| SCHEMBL22771166 | 0.83 | LMNA (0.50) | — | |
| SCHEMBL16134189 | 0.83 | LMNA (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 416 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1347780-B1 | COMPOSITIONS OF N-(METHYLETHYLAMINOCARBONYL)-4-(3-METHYLPHENYLAMINO)-3-PYRIDYLSULFONAMIDE AND CYCLIC OLIGOSACCHARIDES | PLIVA PHARM & CHEM WORKS (HR) | 2007-01-03 | — | — | EP | claimed |
| US-7037928-B2 | Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides | PLIVA, FARMACEUTSKA INDUSTRIJA, DIONICKO DRUSTVO (HR) | 2006-05-02 | — | — | US | claimed |
| JP-2004513155-A | — | — | 2004-04-30 | — | — | JP | claimed |
| US-20040039204-A1 | Compositions of n-(methylethaylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosacccharides | PLIVA FARMACEUTSKA INDUSTRIJ, DIONICKO DRUSTVO (HR) | 2004-02-26 | — | — | US | claimed |
| EP-1347780-A1 | COMPOSITIONS OF N-(METHYLETHYLAMINOCARBONYL)-4-(3-METHYLPHENYLAMINO)-3-PYRIDYLSULFONAMIDE AND CYCLIC OLIGOSACCHARIDES | Pliva, Farmaceutska, Industrija, Dionicko Drustvo (HR) | 2003-10-01 | — | — | EP | claimed |
| WO-2002038186-A1 | COMPOSITIONS OF N-(METHYLETHYLAMINOCARBONYL)-4-(3-METHYLPHENYLAMINO)-3-PYRIDYLSULFONAMIDE AND CYCLIC OLIGOSACCHARIDES | PLIVA, FARMACEUTSKA INDUSTRIJA, DIONICKO DRUSTVO (HR) | 2002-05-16 | — | — | WO | claimed |
| WO-1998035677-A1 | NON-SEDATING HISTAMINE ANTAGONIST COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | BRIDGE PHARMA, INC. (US) | 1998-08-20 | — | — | WO | claimed |
| US-11939324-B2 | Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disorders | REMYND N.V. (BE) | 2024-03-26 | — | — | US | disclosed |
| EP-3621963-B1 | COMPOUNDS FOR THE TREATMENT OF EPILEPSY, NEURODEGENERATIVE DISORDERS AND OTHER CNS DISORDERS | REMYND N V (BE) | 2024-01-24 | — | — | EP | disclosed |
| WO-2023241799-A1 | FLAVANOLS FOR USE IN THE TREATMENT OF RETROVIRAL INFECTIONS | Université Libre de Bruxelles (BE) | 2023-12-21 | — | — | WO | disclosed |
| US-20230130598-A1 | PYRROLOPYRIDINE AND IMIDAZOPYRIDINE ANTIVIRAL COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-04-27 | — | — | US | disclosed |
| US-20230099111-A1 | COMPOUNDS FOR THE TREATMENT OF EPILEPSY, NEURODEGENERATIVE DISORDERS AND OTHER CNS DISORDERS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-03-30 | — | — | US | disclosed |
| WO-2023046900-A1 | RIBONUCLEOSIDE ANALOGUES AGAINST -SARS-COV-2 | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-03-30 | — | — | WO | disclosed |
| EP-0573473-A1 | 4- (2-BENZOTHIAZOLYL)METHYLAMINO]--g(a)- (3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL. | JANSSEN PHARMACEUTICA NV (BE) | 1993-12-15 | — | — | EP | disclosed |
| WO-1993019061-A1 | ITRACONAZOLE AND SAPERCONAZOLE STEREOISOMERS | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-09-30 | — | — | WO | disclosed |
| WO-1993009118-A1 | 1,3-DIHYDRO-2H-IMIDAZO(4,5-B)QUINOLIN-2-ONE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-05-13 | — | — | WO | disclosed |
| EP-0541153-A1 | 1,3-Dihydro-2H-imidazo[4,5-b]-quinolin-2-one derivatives as phosphodiesterase inhibitors | JANSSEN PHARMACEUTICA N.V. (BE) | 1993-05-12 | — | — | EP | disclosed |
| EP-0503710-A2 | Flunarizine containing anti-neoplastic compositions | JANSSEN PHARMACEUTICA N.V. (BE) | 1992-09-16 | — | — | EP | disclosed |
| WO-1992014731-A1 | 4-[(2-BENZOTHIAZOLYL)METHYLAMINO]-α-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL | JANSSEN PHARMACEUTICA N.V. (BE) | 1992-09-03 | — | — | WO | disclosed |
| EP-0501552-A1 | 4-[(2-Benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol | JANSSEN PHARMACEUTICA N.V. (BE) | 1992-09-02 | — | — | EP | disclosed |